Publications by authors named "Rosemay Dray-Spira"
Article Synopsis
- The study aimed to compare the risks of major adverse cardiovascular events (MACEs) and venous thromboembolism events (VTEs) between patients using Janus kinase inhibitors (JAKi) and adalimumab for rheumatoid arthritis.
- A large cohort of 15,835 patients from France was analyzed, finding that the risk of MACEs and VTEs for those on JAKi was not significantly different from those on adalimumab.
- Overall, the results provide reassurance regarding the cardiovascular safety of JAKi in comparison to adalimumab, even for patients with pre-existing cardiovascular risk factors.
Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig . Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.
Emilie Sbidian Laetitia Penso Philippe Herlemont Jérémie Botton Bérangère Baricault Rosemay Dray-Spira
Ann Rheum Dis
May 2023